Protara Therapeutics Share Price (NASDAQ: TARA)
$3.1
Last updated on
Check the interactive Protara Therapeutics Stock chart to analyse performance
Protara Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$3.10Today's High:$3.19
0.0%
Downside
Day's Volatility :2.67%
Upside
2.67%
- 52 Weeks Low:$1.6052 Weeks High:$10.48
48.55%
Downside
52 Weeks Volatility :84.78%
Upside
70.42%
Protara Therapeutics Stock Returns
Protara Therapeutics Inc Key Stats
Check Protara Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Protara Therapeutics Stock including INR - Dollar returns
The Protara Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Protara Therapeutics investment value today
Current value as on today
₹1,60,284
Returns
₹60,284
(+60.28%)
Returns from Protara Therapeutics Stock
₹55,000 (+55%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Protara Therapeutics Stock
Global Institutional Holdings in Protara Therapeutics Inc
Name
Holdings %
HHG PLC
10.63%
Velan Capital Investment Management LP
5.54%
Blackstone Inc
4.95%
Vanguard Group Inc
4.67%
Catalio Capital Management, LP
4.22%
Integral Health Asset Management, LLC
3.63%
Analyst Recommendation on Protara Therapeutics Stock
Buy
90%Buy
9%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Protara Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Protara Therapeutics Share Price Target
What analysts predicted
Upside of 680.65%
Target:
$24.20
Current:
$3.10
Protara Therapeutics share price target is $24.20, a slight Upside of 680.65% compared to current price of $3.10 as per analysts' prediction.
Protara Therapeutics Stock Insights
Price Movement
In the last 1 year, TARA stock has moved up by 55.5%TARA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 14.4%TARA vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 121.9%
Protara Therapeutics Technicals Summary
Sell
Neutral
Buy
Protara Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Protara Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 1.63% | -9.59% | 61.98% | -4.6% | -84.84% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.48 | -0.43 | -0.28 | NA | 3.74 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $121.1M | -84.84% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Protara Therapeutics Inc
Key Management of Protara Therapeutics Inc
Important FAQs about investing in TARA Stock from India :
What is Protara Therapeutics share price today?
Protara Therapeutics share price today is $3.10 as on at the close of the market. Protara Therapeutics share today touched a day high of $3.19 and a low of $3.10.
What is the 52 week high and 52 week low for Protara Therapeutics share?
Protara Therapeutics share touched a 52 week high of $10.48 and a 52 week low of $1.60. Protara Therapeutics stock price today i.e. is closed at $3.10, lower by 70.42% versus the 52 week high.
How to invest in Protara Therapeutics Stock (TARA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Protara Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protara Therapeutics Shares that will get you 0.4839 shares as per Protara Therapeutics share price of $3.10 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Protara Therapeutics Stock (TARA) from India?
Indian investors can start investing in Protara Therapeutics (TARA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Protara Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Protara Therapeutics share’s latest price of $3.10 as on August 30, 2025 at 1:29 am IST, you will get 3.2258 shares of Protara Therapeutics. Learn more about
fractional shares .
What are the returns that Protara Therapeutics has given to Indian investors in the last 5 years?
Protara Therapeutics stock has given -84.84% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%